D-0434-2022 Class II Terminated
FDA drug recall D-0434-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 63 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 2, 2022
- Initiation Date
- Dec 6, 2021
- Termination Date
- Jun 7, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 63 vials
Product description
Dibutyl Squaric Acid, Topical Solution (PF), Multiple Dose Vial, 2%, 10 mL per vial, Edge Pharma, LLC, 856 Hercules Dr, Colchester VT, 05446, NDC 05446-1047-03
Reason for recall
CGMP Deviations
Distribution pattern
nationwide
Code information
09-2021-15@5 12-14-2021 & 10-2021-01@4 12-30-2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0434-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026